Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers
Jiaxuan Xu, Xiaoqing Dong, David C.S. Huang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4957-4957
Open Access | Times Cited: 17

Showing 17 citing articles:

Integrating machine learning and structural dynamics to explore B-cell lymphoma-2 inhibitors for chronic lymphocytic leukemia therapy
Rikki R. Bharadwaj, Amer M. Alanazi, Vivek Dhar Dwivedi, et al.
Molecular Diversity (2025)
Closed Access
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
Andrew D. Hughes, Petri Pölönen, David T. Teachey
Haematologica (2025)
Open Access
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 5
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas
Francesco D’Alò, Silvia Bellesi, Elena Maiolo, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2243-2243
Open Access | Times Cited: 3
Apoptotic and Nonapoptotic Cell Death in Caenorhabditis elegans Development
Lauren Bayer Horowitz, Shai Shaham
Annual Review of Genetics (2024) Vol. 58, Iss. 1, pp. 113-134
Closed Access | Times Cited: 3
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Hyeonji Yoo, Yeon-Jin Kim, Jinseong Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 3994-3994
Open Access | Times Cited: 3
Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential
Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 3
MNDA, a PYHIN factor involved in transcriptional regulation and apoptosis control in leukocytes
Stefania Bottardi, Taylorjade Layne, Ailyn C. Ramòn, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Synthesis of novel ( R )-carvone-tagged thiazolidinone as anticancer leads: characterization, in vitro antiproliferative evaluation and in silico studies
Yassine Riadi, Obaid Afzal, Shashank Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access
Combination of fruquintinib with venetoclax for the treatment of colorectal cancer
Wei Zhang, Weicheng Wang, Rui Wang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 1, pp. 225-234
Closed Access
Development of chromone-thiazolidine-2,4-dione Knoevenagel conjugates as apoptosis inducing agents
Mary Sravani Galla, Nandini B. Kale, Anamika Sharma, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 109, pp. 129853-129853
Closed Access
Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications
David Gorodezki, Martin U. Schuhmann, Martin Ebinger, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1215-1215
Open Access
The Interplay between Autophagy and Mitochondria in Cancer
Aleksandra Zdanowicz, Emilia Grosicka-Maciąg
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9143-9143
Open Access
Ozone: complicated effects in central nervous system diseases
Xu Zhang, Shijun Wang, Si-Cen Wan, et al.
Medical Gas Research (2024) Vol. 15, Iss. 1, pp. 44-57
Closed Access
Discovery of novel azo pyrimidinone derivatives as B-cell lymphoma-2 inhibitors with potential antineoplastic activity: Synthesis, characterization, in-silico, and in-vitro studies
Ahmed A. Noser, Abd-Al-Baqer Alkhikany, Maha M. Salem, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140783-140783
Closed Access
Reappraisal of the fundamental mechanisms of the sHA14-1 molecule as a Bcl-2/Bcl-XL ligand in the context of anticancer therapy: A cell biological study
Aoula Moustapha, Pauline Andreu, François Gonzalvez, et al.
Journal of Biological Methods (2024) Vol. 11, Iss. 4, pp. e99010040-e99010040
Open Access
Evaluación del potencial inmunogénico de la proteína bax como potencial diana terapeuta contra el cancer: reporte breve
Luis Fabián Salazar-Garcés, Diana Catalina Velasteguí Hernández, Lizette Elena Leiva Suero
Salud Ciencia y Tecnología - Serie de Conferencias (2023) Vol. 2, pp. 587-587
Closed Access
Page 1

Scroll to top